C. L. Benhamou, J. C. Souberbielle, and B. Cortet, La vitamine D chez l'adulte : recommandations du GRIO, Presse Med, vol.40, pp.673-682, 2011.

H. Bischoff-ferrari, W. Willett, and E. Orav, A pooled analysis of vitamin D dose requirements for fracture prevention, N Engl J Med, vol.367, pp.40-49, 2012.

H. Bischoff-ferrari, B. Dawson-hughes, and H. B. Staehelin, Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials, BMJ, vol.339, p.3692, 2009.

A. Carmel, A. Shieh, H. Bang, and R. Blockman, The 25(OH)D level to maintain a favourable bisphosphonate response is > 33 ng/mL, Osteoporos Int, vol.23, pp.2479-2487, 2012.

J. C. Souberbielle, J. J. Body, and J. M. Lappe, Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice

, Autoimmunity Reviews, vol.9, pp.709-715, 2010.

T. Larsen, F. Mose, and J. Bech, Effect of cholecalciferol supplementation during winter months in patients with hypertension : a randomized placebo-controlled trial, Am J Hypertension, 2012.

C. 7-mason, X. L. Imayama, and I. , Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial, Am J Clin Nutr, vol.99, pp.1015-1025, 2014.

M. Holick, N. Binkley, and H. Bischoff-ferrari, Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, vol.96, pp.1911-1930, 2011.

J. Adams and M. Hewison, Update in vitamin D, J Clin Endocrinol Metab, vol.95, pp.471-478, 2010.

D. Hanley, A. Cranney, and G. Jones, Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada, CMAJ, vol.182, pp.610-618, 2010.

C. Ross, J. E. Manson, and S. Abrams, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine : what clinicians need to know, J Clin Endocrinol Metab, vol.96, pp.53-58, 2011.

M. Luxwolda, R. Kuiperst, and I. Kema, Traditionnally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L, British Journal of Nutrition, vol.108, pp.1557-1561, 2012.

J. Hathcock, A. Shao, and R. Vieth, Risk assessment for vitamin D, Am J Clin Nutr, vol.85, pp.6-18, 2007.

J. -eisman, When is a U-curve actually a J-curve? Is it really too much of a good thing, J Clin Endocrinol Metab, vol.98, pp.1863-1864, 2013.

J. C. Souberbielle, C. Massart, and S. Brailly-tabard, Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study, Endocrine, vol.53, pp.543-50, 2016.

M. -vernay, M. Sponga, and B. Salanave, Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values, J Clin Endocrinol Metab, vol.99, pp.1196-1203, 2006.

J. C. Souberbielle, C. L. Benhamou, and B. Cortet, Ostéopathies fragilisantes, maladie rénale chronique, malabsorptions, anomalies biologiques du métabolisme phospho-calcique : les (Paris), vol.72, pp.385-389, 2015.

L. Tafaro, G. Nati, and E. Leoni, Adherence to anti-osteoporotic therapies: role and determinants of "spot therapy, Osteoporos Int, vol.24, pp.2319-2323, 2013.

L. -armas, B. W. Hollis, and R. P. Heaney, Vitamin D2 is much less effective than vitamin D3 in humans, J Clin Endocrinol Metab, vol.89, pp.5387-5391, 2004.

K. M. Sanders, A. L. Stuart, and E. J. Williamson, Effect of annual intramuscular vitamin D on fracture risk in elderly men and women -A population-based, randomized, double-blind, placebo-controlled trial, Rheumatology, vol.303, issue.23, pp.1852-1857, 2007.

V. V. -välimäki, E. Löyttyniemi, and T. Pekkarinen, How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? a placebo-controlled study Endocrinol (Oxf), vol.84, pp.837-844, 2016.

A. L. Darling, K. H. Hart, and M. A. Gibbs, Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption, Osteoporos Int, vol.25, pp.933-941, 2014.

S. -ish-shalom, E. Segal, and T. Salganik, Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients, J Clin Endocrinol Metab, vol.93, pp.3430-3435, 2008.

H. -bischoff-ferrari, B. Dawson-hughes, and A. Platz, Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture, Arch Int Med, vol.170, pp.813-820, 2010.

S. Cummings, D. P. Kiel, and D. M. Black, Vitamin D supplementation and increased risk of falling: a cautionary tale of vitamin D supplement retold, JAMA Intern Med, vol.176, pp.171-172, 2016.

H. S. -choi, Y. Min, and D. W. Byun, Korean Society for Bone and Mineral research task force report: perspectives on intermittent high-dose vitamin D supplementation, J Bone Metab, vol.24, pp.141-145, 2017.

B. Hollis and C. Wagner, The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes, J Clin Endocrinol Metab, vol.98, pp.4619-4628, 2013.

R. -vieth, How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology, Anticancer Res, vol.29, pp.3675-3784, 2009.

S. Muir and M. Montero-odasso, Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis, J Am Geriatr Soc, vol.59, pp.2291-2300, 2011.

A. Martineau, D. Jolliffe, and R. Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ, 2017.